Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
11-20190----1件: 93 💬
211C-CSar----2件: 93, 94 💬
313-15mg/kg/d Ursodeoxycholic----1件: 93 💬
418-22mg/kg/d Ursodeoxycholic----1件: 93 💬
53 mg [14C]-A4250 capsule----3件: 93, 297, 338 💬
63-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-----1件: 93 💬
73-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic acid----1件: 93 💬
83a,7a-dihydroxy-6a-ethyl-5betacholan-24-oic acid----1件: 93 💬
93a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid----1件: 93 💬
106 alpha-ethylchenodeoxycholic acid (6-EDCA), OCA, INT-747----1件: 93 💬
116-ECDCA1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
126-ethylchenodeoxycholic acid1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
136?-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-7471件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
146a-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-7471件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
156a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
166a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
176a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o, obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
186a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
196a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
206a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
216a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
226a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o , obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
236a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
246a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o , obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
25A11HA02----1件: 93 💬
26A4250----4件: 93, 296, 297, 338 💬
27Abatacept1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
28Acido Obeticolico----2件: 93, 94 💬
29Acido ursodessicolico----1件: 93 💬
30Alkaline Phosphatase1件: Alkaline Phosphatase---4件: 46, 93, 97, 172 💬
31APD334----5件: 93, 96, 97, 98, 269 💬
32ASC42 10 mg----1件: 93 💬
33ASC42 15 mg----1件: 93 💬
34ASC42 5 mg----1件: 93 💬
35Atorvastatin1件: Atorvastatin1件: Atorvastatin 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬19件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
36Azathioprine1件: Azathioprine1件: Azathioprine 💬 --21件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 💬
37Baricitinib1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬13件: 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
38BCD-085----2件: 93, 271 💬
39Bezafibrat----1件: 93 💬
40Bezafibrat Genericon retard 400 mg----1件: 93 💬
41Bezafibrate1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬7件: 20, 93, 94, 160, 296, 316, 324 💬
42Bezafibrate 200 MG1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
43Bezafibrate 200 MG Oral Tablet1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
44Bezafibrate 400 MG1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
45Bezafibrate IR1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
46Bezafibrate SR1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
47Bezafibrate, Beza, BZF, Bezalip1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
48Bezafibrate, Beza, BZF, Bezalip mono1件: Bezafibrate1件: Bezafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
49Bezafilbrate IR----1件: 93 💬
50Bezalip----3件: 93, 94, 160 💬
51Bezalip mono----1件: 93 💬
52Budenofalk 3mg----2件: 93, 97 💬
53BUDESONIDE1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬9件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
54Calcium2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--27件: 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬
55Choline1件: Choline1件: Choline 💬 --4件: 93, 171, 193, 299 💬
56Cilofexor1件: Cilofexor---2件: 93, 94 💬
57CNP-104----1件: 93 💬
58CNTO1275----6件: 46, 49, 84, 93, 96, 97 💬
59Colchicine1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬7件: 2, 42, 46, 56, 93, 210, 266 💬
60Combination antiviral therapy----1件: 93 💬
61CR845 1.0 mg----1件: 93 💬
62CRC (A3384)----3件: 93, 297, 338 💬
63CS0159----2件: 93, 94 💬
64Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬
65Cyclosporin1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬
66Cyclosporin A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬11件: 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 💬
67Denosumab1件: Denosumab1件: Denosumab 💬 1件: TNFSF11 💬 8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬8件: 46, 50, 70, 93, 95, 96, 274, 299 💬
68E6011----3件: 46, 93, 96 💬
69EDP-305----1件: 93 💬
70EDP-305 Dose 1----1件: 93 💬
71EDP-305 Dose 2----1件: 93 💬
72ELAFIBRANOR1件: Elafibranor1件: Elafibranor 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 93, 94 💬
73Elafibranor 120 mg1件: Elafibranor1件: Elafibranor 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 93, 94 💬
74Elafibranor 80 mg1件: Elafibranor1件: Elafibranor 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 93, 94 💬
75Elafibranor 80mg1件: Elafibranor1件: Elafibranor 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
76Emtricitabine1件: Emtricitabine1件: Emtricitabine 💬 --4件: 25, 93, 265, 325 💬
77Emtricitabine (FTC)/Tenofovir Disoproxil (TDF)3件: Emtricitabine,
Tenofovir,
Tenofovir disoproxil		2件: Emtricitabine ,
Tenofovir 💬 		--1件: 93 💬
78EP547----2件: 93, 94 💬
79Experimental: Seladelpar / MBX-8025 200 mg1件: Seladelpar1件: Seladelpar 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
80Experimental: Seladelpar / MBX-8025 50 mg1件: Seladelpar1件: Seladelpar 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
81Ezetimibe1件: Ezetimibe1件: Ezetimibe 💬 1件: NPC1L1 💬 1件: Fat digestion and absorption 💬4件: 49, 79, 93, 260 💬
82Ezetrol1件: Ezetimibe1件: Ezetimibe 💬 1件: NPC1L1 💬 1件: Fat digestion and absorption 💬2件: 93, 260 💬
83EZT----1件: 93 💬
84Fenofibrate1件: Fenofibrate1件: Fenofibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬6件: 8, 79, 93, 94, 97, 265 💬
85Fenofibrate 200mg1件: Fenofibrate1件: Fenofibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
86Fenofibrate Combined With Ursodeoxycholic Acid2件: Fenofibrate,
Ursodeoxycholic acid		2件: Fenofibrate ,
Ursodiol 💬 		2件: NR1H4,
PPARA 💬 		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
87Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)1件: Fenofibrate1件: Fenofibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
88FFP104----2件: 93, 96 💬
89Fully human monoclonal antibody directed against CXCL10----1件: 93 💬
90Fuzhenghuayu----1件: 93 💬
91Genetic analysis----6件: 34, 85, 90, 93, 94, 96 💬
92GFT505----2件: 93, 94 💬
93GKT137831----2件: 85, 93 💬
94Gold1件: Gold---43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 💬
95GOLEXANOLONE----1件: 93 💬
96GR3027----1件: 93 💬
97GS-9674----2件: 93, 94 💬
98GS-9674 100 mg----1件: 93 💬
99GS-9674 30 mg----1件: 93 💬
100GSK2330672----1件: 93 💬
101GSK2330672/linerixibat 40 mg----1件: 93 💬
102GYPP-06 (GKT137831 free base), C10071301-D----1件: 93 💬
103Hesperidin1件: Hesperidin1件: Hesperidin 💬 --2件: 46, 93 💬
104High protein high fiber diet----2件: 93, 95 💬
105ICG----2件: 93, 94 💬
106INT-747----1件: 93 💬
107INT-747, OCA----2件: 93, 94 💬
108Kaletra1件: Lopinavir1件: Lopinavir 💬 --1件: 93 💬
109Linerixibat----1件: 93 💬
110Linerixibat (GSK2330672) 40 mg----1件: 93 💬
111Linerixibat (GSK2330672) 45 mg----1件: 93 💬
112Linerixibat (GSK2330672) 45mg----1件: 93 💬
113LJN452----1件: 93 💬
114LJN452, 0,01 mg----1件: 93 💬
115LJN452, 0,03 mg----1件: 93 💬
116LJN452, 0,1 mg----1件: 93 💬
117LUM001----4件: 93, 94, 297, 338 💬
118LY3009104----6件: 46, 49, 50, 93, 107, 325 💬
119MabThera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬
120Mabthera®1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬6件: 13, 35, 43, 44, 46, 93 💬
121Magnesium1件: Magnesium---15件: 6, 11, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬
122MBX 8025----1件: 93 💬
123MBX-8025----3件: 79, 93, 94 💬
124MBX-8025, DSIC----1件: 93 💬
125MBX-8025, Formulation 2----1件: 93 💬
126Mesenchymal stem cell----2件: 2, 93 💬
127Methionine1件: Methionine1件: Methionine 💬 --6件: 34, 84, 93, 229, 298, 300 💬
128Methotrexate1件: Methotrexate1件: Methotrexate 💬 2件: DHFR,
DHFR2 💬 		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
129Methylprednisolone1件: Methylprednisolone1件: Methylprednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
130Methylprednisolone and azathioprine2件: Azathioprine,
Methylprednisolone		2件: Azathioprine ,
Methylprednisolone 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 93, 95 💬
131Methylprednisolone and Mycophenolate mofetil3件: Methylprednisolone,
Mycophenolate mofetil,
Mycophenolic acid		3件: Methylprednisolone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬 		3件: IMPDH1,
IMPDH2,
NR3C1 💬 		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬2件: 93, 95 💬
132Minodronic acid1件: Minodronic acid---4件: 6, 46, 93, 95 💬
133MODAFINIL1件: Modafinil1件: Modafinil 💬 --4件: 6, 13, 49, 93 💬
134Moexipril1件: Moexipril1件: Moexipril 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 93 💬
135MXB-8025----1件: 93 💬
136Mycophenolate1件: Mycophenolic acid1件: Mycophenolic acid 💬 2件: IMPDH1,
IMPDH2 💬 		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬36件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
137Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬 		2件: IMPDH1,
IMPDH2 💬 		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬34件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
138NCA 500mg----1件: 93 💬
139NGM282----2件: 93, 94 💬
140NI-0801----1件: 93 💬
141Non-myeloablative Hematopoietic Stem Cell Transplantation----1件: 93 💬
142Norucholic acid1件: norUrsodeoxycholic acid---2件: 93, 94 💬
143Norucholic acid (NCA) 500 mg1件: norUrsodeoxycholic acid---1件: 93 💬
144Obeticholic Acid1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬3件: 93, 265, 296 💬
145Obeticholic Acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
146Obeticholic Acid 10 MG1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
147Obeticholic Acid 5 MG1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
148Obeticholic Acid Tablets1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
149OCA (INT-747)----1件: 93 💬
150OCA, INT-747----1件: 93 💬
151Ocaliva1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬2件: 93, 296 💬
152Ocaliva 10mg1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
153Ocaliva 5mg1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
154Olumiant1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬4件: 46, 49, 93, 107 💬
155Part 1: LJN452----1件: 93 💬
156Part 2: LJN452 Dose level 1----1件: 93 💬
157Part 2: LJN452 Dose level 2----1件: 93 💬
158Pemafibrate1件: Pemafibrate1件: Pemafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
159Pentoxifylline1件: Pentoxifylline1件: Pentoxifylline 💬 --12件: 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298 💬
160PHENYLBUTYRATE1件: Phenylbutyric acid---12件: 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338 💬
161Potassium1件: Potassium1件: Potassium 💬 --13件: 36, 46, 66, 67, 88, 93, 94, 98, 115, 167, 179, 215, 235 💬
162Probiotic----8件: 2, 6, 93, 96, 97, 193, 266, 299 💬
163PYRIDOXINE1件: Pyridoxine1件: Pyridoxine 💬 --3件: 93, 145, 320 💬
164Pyridoxine 10mg1件: Pyridoxine1件: Pyridoxine 💬 --1件: 93 💬
165Pyridoxine 10mg BP1件: Pyridoxine1件: Pyridoxine 💬 --1件: 93 💬
166Questran1件: Cholestyramine---4件: 93, 254, 297, 338 💬
167Raltegravir1件: Raltegravir1件: Raltegravir 💬 --4件: 13, 26, 93, 265 💬
168RhuDex 100 mg (127 mg RhuDex choline salt) granules1件: Choline1件: Choline 💬 --1件: 93 💬
169RhuDex 25 mg (31.75 mg RhuDex choline salt) granules1件: Choline1件: Choline 💬 --1件: 93 💬
170RhuDex 50 mg (63.5 mg RhuDex choline salt) granules1件: Choline1件: Choline 💬 --1件: 93 💬
171RhuDex choline salt1件: Choline1件: Choline 💬 --1件: 93 💬
172Rifampicin1件: Rifampicin1件: Rifampin 💬 --6件: 6, 17, 46, 93, 299, 338 💬
173Rifaximin1件: Rifaximin1件: Rifaximin 💬 --8件: 6, 65, 93, 96, 97, 99, 296, 299 💬
174Risedronic acid1件: Risedronic acid1件: Risedronic acid 💬 1件: FDPS 💬 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 93, 95, 274 💬
175RITUXIMAB1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
176S-adenosyl-L-methionine1件: Methionine1件: Methionine 💬 --1件: 93 💬
177S-adenosyl-methionine (SAMe) capsules2件: Ademetionine,
Methionine		2件: Methionine ,
Ademetionine 💬 		--1件: 93 💬
178SAMe1件: Ademetionine1件: Ademetionine 💬 --1件: 93 💬
179Saroglitazar1件: Saroglitazar---1件: 93 💬
180SAROGLITAZAR MAGNESIUM2件: Magnesium,
Saroglitazar		---1件: 93 💬
181Saroglitazar Magnesium 1 mg2件: Magnesium,
Saroglitazar		---1件: 93 💬
182Saroglitazar Magnesium 2 mg2件: Magnesium,
Saroglitazar		---1件: 93 💬
183Saroglitazar magnesium 4 mg2件: Magnesium,
Saroglitazar		---1件: 93 💬
184SELADELPAR1件: Seladelpar1件: Seladelpar 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬2件: 93, 94 💬
185Seladelpar 10 mg1件: Seladelpar1件: Seladelpar 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
186Seladelpar 10 mg Capsule1件: Seladelpar1件: Seladelpar 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
187Seladelpar 10 mg or less1件: Seladelpar1件: Seladelpar 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
188Seladelpar 5 mg1件: Seladelpar1件: Seladelpar 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
189Seladelpar 5 mg Capsule1件: Seladelpar1件: Seladelpar 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
190Seladelpar 5-10 mg1件: Seladelpar1件: Seladelpar 💬 1件: PPARG 💬 11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
191SETANAXIB1件: Setanaxib---1件: 93 💬
192Sortis----1件: 93 💬
193Sortis 10 mg----1件: 93 💬
194Standard of Care: UDCA1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
195Sublimated mare milk----1件: 93 💬
196TAUROURSODEOXYCHOLIC ACID1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬 --3件: 2, 93, 299 💬
197Tauroursodeoxycholic Acid Capsules1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬 --1件: 93 💬
198Tenofovir2件: Tenofovir,
Tenofovir disoproxil		1件: Tenofovir 💬 --6件: 2, 13, 25, 93, 265, 325 💬
199Tenofovir disoproxil2件: Tenofovir,
Tenofovir disoproxil		1件: Tenofovir 💬 --2件: 93, 265 💬
200Tetrathiomolybdate1件: Tetrathiomolybdate---3件: 85, 93, 171 💬
201Thiamine1件: Thiamine1件: Thiamine 💬 --3件: 8, 93, 265 💬
202Tiamin DAK----1件: 93 💬
203Tiamin SAD----1件: 93 💬
204Tigecycline1件: Tigecycline1件: Tigecycline 💬 --1件: 93 💬
205TQA3526----1件: 93 💬
206Tropifexor1件: Tropifexor1件: Tropifexor 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
207Truvada and Kaletra1件: Lopinavir1件: Lopinavir 💬 --1件: 93 💬
208UDCA1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬6件: 46, 67, 93, 94, 97, 296 💬
209UDCA (Ursodeoxycholic acid)1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
210Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation----2件: 93, 296 💬
211Ursodeoxycholic acid1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬10件: 6, 46, 67, 84, 93, 94, 95, 96, 97, 296 💬
212Ursodeoxycholic Acid (URSO)1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
213Ursodeoxycholic Acid 300mg capsule1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
214Ursodeoxycholic Acid 300mg tablet1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
215Ursodeoxycholic Acid Capsules1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
216Ursodeoxycholic acid combination of immunosuppressive agents1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬2件: 93, 95 💬
217Ursodeoxycholic acid combined with total glucosides of paeony1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
218Ursodeoxycholic acid only1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
219Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)2件: Methylprednisolone,
Ursodeoxycholic acid		2件: Methylprednisolone ,
Ursodiol 💬 		2件: NR1H4,
NR3C1 💬 		2件: Bile secretion, Neuroactive ligand-receptor interaction 💬1件: 93 💬
220Ursodeoxycholsäure----1件: 93 💬
221Ursodiol1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬6件: 8, 20, 93, 97, 234, 299 💬
222Ursofalk1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬4件: 93, 94, 96, 97 💬
223Ursofalk® 500 mg film-coated tablets1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
224Ursofalk® 500 mg Filmtabletten1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
225Ursofalk® capsules1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
226Ustekinumab1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬16件: 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
227Ustekinumab 180 mg1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 93 💬
228Ustekinumab 45 mg1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 93 💬
229Ustekinumab 90 mg1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬3件: 49, 93, 96 💬
230Vitamin D2件: Cholecalciferol,
Vitamin D		1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬20件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 298, 299 💬
231Volixibat1件: Volixibat1件: Volixibat 💬 --2件: 93, 94 💬
232Volixibat potassium2件: Potassium,
Volixibat		2件: Potassium ,
Volixibat 💬 		--2件: 93, 94 💬
233Zoledronic acid1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬 		1件: FDPS 💬 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬12件: 5, 6, 13, 17, 46, 93, 95, 96, 270, 274, 299, 333 💬